Abstract
The chapter analyzes the most common neurological disorders, mainly myelodysplasia, which deal with neurogenic bladder dysfunction (NBD). The pathophysiology and the consequences on urinary continence and urological/renal function are described. Management of NBD in children has undergone major changes over the years. Reliable urodynamic investigation (UDS), the advent of clean intermittent catheterization (CIC), a plethora of drug therapies that modulate lower urinary tract function, a multitude of rehabilitative modalities, and advancement in surgical techniques had furnished the evidence-based ways and tools to manage neurogenic bladder in children.
The steps of a clinical workup, both for those conditions starting at birth and the occult lesions detected later on, are underlined. The main goals of treatment remain the prevention of urinary tract deterioration and the achievement of continence.
The newborn must be protected by those “at-risk” bladders, which can significantly alter renal function. While continence is usually addressed as the child reaches school age, issues such as elevated detrusor pressure, hydronephrosis and/or reflux, and chronic UTIs are treated at any time.
Nowadays, the treatment of choice is initially conservative. Multiple conservative modalities, i.e., pharmacologic agents, medical devices, and neuromodulation, should be promoted before undertaking surgical interventions. Intermittent catheterization and drug therapy are usually sufficient for maintaining continence and preserving upper tracts. Surgical procedures should be considered if conservative measures fail to achieve continence between catheterizations or preserve upper tracts.
The improvement of quality of life is the final goal. It is a difficult concept to measure because of lack of validated instruments and difficulties in translating from one culture or language to another.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- BTX:
-
Botox
- CNS:
-
Central nervous system
- DLPP:
-
Detrusor leak point pressure
- DO:
-
Detrusor overactivity
- DSD:
-
Detrusor sphincter dyssynergia
- EMG:
-
Electromyography
- LPP:
-
Leak point pressure
- LUT:
-
Lower urinary tract
- LUTD:
-
Lower urinary tract dysfunction
- MRI:
-
Magnetic resonance imaging
- NBD:
-
Neurogenic bladder dysfunction
- NDSD:
-
Neurogenic detrusor sphincter dysfunction
- QoL:
-
Quality of life
- RNC:
-
Renal nuclear cystography
- UDS:
-
Urodynamics
- UTI:
-
Urinary tract infection
- VCUG:
-
Voiding cystourethrography
- VUR:
-
Vesicoureteral reflux
References
Bauer SB (2003) The management of the myelodysplastic child: a paradigm shift. BJU Int 92:23–28
Lapides J, Diokno AC, Silber SJ et al (1972) Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107:458–462
Bauer SB (1985) The management of spina bifida from birth onwards. In: Whitaker RH, Woodard JR (eds) Paediatric urology. Butterworths, London, pp 87–112
Hunt GM, Whitaker RH (1987) The pattern of congenital renal anomalies associated with neural tube defects. Dev Med Child Neurol 29:91–95
Kasabian NG et al (1992) The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 146:480–487
Wang SC et al (1989) Urethral dilatation in the management of urological complications of myelodysplasia. J Urol 142:1054–1055
Szabó L, Lombay B, Borbás E, Bajusz I (2004) Videourodynamics in the diagnosis of urinary tract abnormalities in a single center. J Pediatr Nephrol 19(3):326–331. doi:10.1007/s00467-003-1341-8
McGuire EJ et al (1981) Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 126(2):205–209
Wang QW, Wen JG, Song DK et al (2006) Is it possible to use urodynamic variables to predict upper urinary tract dilatation in children with neurogenic bladder-sphincter dysfunction? BJU Int 98(6):1295–300
Guzman L et al (1983) Evaluation and management of children with sacral agenesis. Urology 22(5):506–510
Abokson H, Holm-Bentzen M, Hald T (1985) The evaluation and management of children with sacral agenesis and dysgenesis. Neurourol Urodyn 4:99
De Gennaro M, Rivosecchi M, Lucchetti MC et al (1994) The incidence of occult spinal dysraphism and the onset of neurovesical dysfunction in children with anorectal anomalies. Eur J Pediatr Surg 4(Suppl 1):12–14
Mosiello G, Capitanucci ML, Gatti C et al (2003) How to investigate neurovesical dysfunction in children with anorectal malformations. J Urol 170(4 Pt 2):1610–1613
Capitanucci ML, Rivosecchi M, Silveri M et al (1996) Neurovesical dysfunction due to spinal dysraphism in anorectal anomalies. Eur J Pediatr Surg 6(3):159–162
Taskinen S, Valanne L, Rintala R (2002) Effect of spinal cord abnormalities on the function of the lower urinary tract in patients with anorectal malformations. J Urol 168:1147–1149
Boemers TM, Beek FJ, van de Gool JD et al (1996) Urologic problems in anorectal malformations. Part 1: urodynamic findings and significance of sacral anomalies. J Pediatr Surg 31:407–410
Generao SE et al (2004) Spinal cord injury in children: long-term urodynamic and urological outcomes. J Urol 172(3):1092–1094; discussion 1094
Silveri M, Salsano L et al (2006) Pediatric spinal cord injury: approach for urological rehabilitation and treatment. J Pediatr Urol 2(1):10–15
Pannek J, Diederichs W, Botel U (1997) Urodynamically controlled management of spinal cord injury in children. Neurourol Urodyn 16(4):285–292
Nosseir M, Hinkel A, Pannek J (2007) Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn 26(2):228–233
Decter RM et al (1987) Urodynamic assessment of children with cerebral palsy. J Urol 138(4 Pt 2):1110–1112
Ersoz M, Kaya K, Erol SK et al (2009) Non invasive evaluation of lower urinary tract function in children with cerebral palsy. Am J Phys Med Rehabil 88(9):735–741
Mosiello G, Gatti C, De Gennaro M et al (2003) Neurovesical dysfunction in children after treating pelvic neoplasms. BJU Int 92(3):289–292
Ozkan KU, Bauer SB, Khoshbin S et al (2006) Neurogenic bladder dysfunction after sacrococcygeal teratoma resection. J Urol 175(1):292–296; discussion 296
Nguyen HT, Sencan A, Silva A et al (2010) Urodynamic studies are recommended in children with central nervous system tumors regardless of location. J Urol 184(6):2516–2520
Bauer SB (2008) Neurogenic bladder: etiology and assessment. Pediatr Nephrol 23:541–551
Meyrat BJ, Tercier S, Lutz N et al (2003) Introduction of a urodynamic score to detect pre- and postoperative neurological deficits in children with a primary tethered cord. Childs Nerv Syst 19:716–721
Satar N, Bauer SB, Scott RM et al (1997) Late effects of early surgery on lipoma and lipomeningocele in children less than 1 year old. J Urol 157:1434–1437
Dik P, Klijn AJ, van Gool JD et al (2006) Early start to therapy preserves kidney function in spina bifida patients. Eur Urol 49(5):908–913
Lais A, Kasabian NG, Dyro FM et al (1993) The neurosurgical implications of continuous neurourological surveillance of children with myelodysplasia. J Urol 150(6):1879–1883
Kumar R, Singhal N, Gupta M et al (2008) Evaluation of clinico-urodynamic outcome of bladder dysfunction after surgery in children with spinal dysraphism – a prospective study. Acta Neurochir (Wien) 150(2):129–137
Capitanucci ML, Iacobelli BD, Silveri M et al (1996) Long-term urological follow-up of occult spinal dysraphism in children. Eur J Pediatr Surg 6(Suppl 1):25–26
Keating MA, Rink RC, Bauer SB et al (1988) Neurourological implications of the changing approach in management of occult spinal lesions. J Urol 140(5 Pt 2):1299–1301
Sidi AA, Dykstra DD, Gonzalez R (1986) The value of urodynamic testing in the management of neonates with myelodysplasia: a prospective study. J Urol 135(1):90–93
McLellan D, Bauer SB (2003) In section on urology, American Academy of Pediatrics, New Orleans
Chou FH et al (2006) Normal ranges of variability for urodynamic studies of neurogenic bladders in spinal cord injury. J Spinal Cord Med 29(1):26–31
Hoebeke P et al (1998) Urodynamics in children: what and how to do it? Acta Urol Belg 66(2):23–30
Van Meel TD, de Wachter S, Wyndaele JJ (2007) Repeated ice water tests and electrical perception threshold determination to detect a neurologic cause of detrusor overactivity. Urology 70(4):772–776
Rosier PFWM, Huo HC, De Gennaro M et al (2013) Urodynamic Testing Patient evaluation: Children. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence. pp 472–488
Andersson KE, Chapple CR, Cardozo L et al (2009) Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol 19:380–384
Game X, Mouracade P, Chartier-Kastler E et al (2009) Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol 5:156–164
Pascali MP, Mosiello M, Marciano A, Capitanucci et al (2011) A simplified technique for Botulinum toxin injections in children with neurogenic bladder. J Urol 185:2558–2562
Pascali MP, Mosiello G, Boldrini R et al (2011) Effects of Botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections. J Urol 185:2552–2557
Lindehall B, Moller A, Hjalmas K et al (1994) Long-term intermittent catheterization: the experience of teenagers and young adults with myelomeningocele. J Urol 152:187–189
Joseph DB, Bauer SB, Colodny AH et al (1989) Clean intermittent catheterization in infants with neurogenic bladder. Pediatrics 84:78–83
Moore KN, Fader M, Getliffe K (2007) Long-term bladder management by intermittentcatheterisation in adults and children. Cochrane Database Syst Rev (2):CD006008
Boone TB, Roehrborn CG, Hurt G (1992) Transurethral intravesical electrotherapy for neurogenic bladder dysfunction in children with myelodysplasia: a prospective, randomized clinical trial. J Urol 148:550–554
De Gennaro M, Capitanucci ML, Mosiello G et al (2011) Current state of nerve stimulation technique for lower urinary tract dysfunction in children. J Urol 185:1571–1577
Guys JM, Haddad M, Planche D et al (2004) Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol 172:1673–1676
Capitanucci ML, Camanni D, Demelas F et al (2009) Long-term efficacy of percutaneous tibial nerve stimulation for different types of lower urinary tract dysfunction in children. J Urol 182:2056–2061
Razmaria AA, Marchetti PE, Prasad SM et al (2013) Does robot-assisted laparoscopic ileocystoplasty (RALI) reduce peritoneal adhesions compared with open surgery? BJU Int. doi:10.1111/bju.12284
Lindley RM, Mackinnon AE, Shipstone D et al (2003) Long-term outcome in bladder detrusorectomy augmentation. Eur J Pediatr Surg 7–1
Chung SY, Meldrum K, Docimo SG (2004) Laparoscopic assisted reconstructive surgery: a 7-year experience. J Urol 171:372–375
Capozza N, Caione P, DeGennaro M et al (1995) Endoscopic treatment of vesicoureteral reflux and urinary incontinence. Technical problems in the pediatric patient. Br J Urol 75:538–542
Guys JM, Simeoni-Alias J, Fakhro A et al (1999) Use of polydimethylsiloxane for endoscopic treatment of urinary incontinence in children. J Urol 162:2133–2135
Gonzalez R, Merino FG, Vaughn M (1995) Long-term results of the artificial urinary sphincter in male patients with neurogenic bladder. J Urol 154:769–770
Catti M, Lortat-Jacob S, Morineau M et al (2008) Artificial urinary sphincter in children—voiding or emptying? An evaluation of functional results in 44 patients. J Urol 180:690–693
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this chapter
Cite this chapter
De Gennaro, M., Mosiello, G. (2015). Neurogenic Bladder. In: Lima, M., Manzoni, G. (eds) Pediatric Urology. Springer, Milano. https://doi.org/10.1007/978-88-470-5693-0_15
Download citation
DOI: https://doi.org/10.1007/978-88-470-5693-0_15
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5692-3
Online ISBN: 978-88-470-5693-0
eBook Packages: MedicineMedicine (R0)